Brugada Syndrome: Diagnostic Criteria and Clinical Symptoms
Diagnostic ECG Criteria
The diagnosis of Brugada syndrome requires a Type 1 ECG pattern showing coved ST-segment elevation ≥2 mm in one or more right precordial leads (V1 and/or V2), positioned in the second, third, or fourth intercostal space, occurring either spontaneously or after sodium channel blocker challenge (ajmaline, flecainide, procainamide, or pilsicainide). 1
Key ECG Features to Identify
- Type 1 Pattern (Diagnostic): Coved rSr' morphology with ST-segment elevation ≥2 mm followed by a negative T-wave in V1-V3 2, 1
- Type 2 Pattern (Non-diagnostic): "Saddle-back" morphology with high takeoff ST-segment elevation ≥2 mm, remaining ≥1 mm above baseline, followed by positive or biphasic T-wave 2
- Type 3 Pattern (Non-diagnostic): Either coved or saddleback morphology with J-point elevation ≥2 mm but terminal ST-segment <1 mm 2
Critical Diagnostic Considerations
- High precordial lead placement (second or third intercostal space) significantly improves detection of Type 1 pattern when standard V1-V2 leads are non-diagnostic 1
- The ECG pattern is highly dynamic and transient, fluctuating between normal and abnormal over time, requiring serial ECGs for diagnosis 1
- Only Type 1 pattern is diagnostic; Types 2 and 3 require sodium channel blocker challenge to unmask Type 1 pattern 2
Clinical Symptoms and Warning Signs
Cardinal Symptoms to Monitor
Syncope is the most critical symptom, particularly when occurring:
- At rest or during sleep (enhanced vagal tone) 1
- Without clear precipitating factors 3
- In patients with spontaneous Type 1 ECG pattern (6-fold higher cardiac arrest risk) 1
Sudden cardiac death or aborted cardiac arrest from polymorphic ventricular tachycardia/ventricular fibrillation 3, 4
Additional Clinical Features
- Seizure-like episodes (actually arrhythmic events misdiagnosed as seizures) 1
- Unexplained nocturnal agonal respirations (arrhythmias during sleep) 1
- Palpitations preceding syncope 4
- Atrial fibrillation (occurs more frequently than in general population) 4
Critical Triggers and Precipitants
Immediate Triggers Requiring Aggressive Management
- Fever: Most critical trigger for ventricular fibrillation requiring early, aggressive antipyretic treatment 3, 1
- Vagotonic states: Rest, sleep, post-prandial state 1
- Electrolyte disturbances: Hyperkalemia, hypercalcemia 2
Medications to Avoid
- Sodium channel blockers (Class I antiarrhythmics) 3
- Psychotropic medications (tricyclic antidepressants, phenothiazines) 3
- Anesthetic agents 3
- Cocaine 3
- Excessive alcohol intake 3, 1
Risk Stratification Framework
Highest Risk (Annual Event Rate 13.5%)
- Cardiac arrest survivors 3
- Spontaneous Type 1 ECG + syncope (presumed ventricular arrhythmia) 3
- Spontaneous Type 1 ECG + ≥2 risk factors (syncope, family history of sudden death <50 years, positive electrophysiologic study) 5
Intermediate Risk (Annual Event Rate 3.2%)
Lower Risk (Annual Event Rate 1%)
- Asymptomatic with spontaneous Type 1 ECG 3
- Drug-induced Type 1 pattern only (very low risk, no chronic therapy needed) 1
Additional ECG Risk Markers
Beyond the Type 1 pattern, the following ECG features indicate increased arrhythmic risk:
- First-degree AV block (PR interval >200 ms) 4, 6
- QRS duration ≥120 ms in V2 4, 6
- Fragmented QRS complex 4, 6
- S wave in lead I (≥40 ms duration, amplitude ≥0.1 mV, area ≥1 mm²) 6
- R wave in lead aVR 6
- Inferior/lateral early repolarization pattern 4, 6
- T-wave alternans (sign of acute electrical instability) 4, 6
Family History Red Flags
- Sudden cardiac death in family members <50 years of age 1
- Unexplained drowning in young family members 1
- Type 1 ECG pattern in family members 1
Practical Clinical Approach
- Confirm Type 1 pattern: Verify correct lead placement, repeat ECG, perform high precordial leads (V1-V2 in 2nd/3rd intercostal space) 1
- Obtain detailed history: Personal syncope/seizures, family history of sudden death <50 years, unexplained drowning, exertional syncope 1
- Refer to electrophysiologist regardless of symptoms when Type 1 pattern is confirmed 1
- Consider sodium channel blocker challenge in patients with suspected Brugada syndrome but no baseline Type 1 pattern 1
- Educate patients about arrhythmia triggers, forbidden drugs, and need for aggressive fever treatment 3, 1
- Screen first-degree relatives with ECG and consider genetic counseling 3, 1
Common Pitfalls
- Missing the diagnosis due to transient ECG changes—serial ECGs are essential 1
- Misdiagnosing as right bundle branch block or early repolarization—use Corrado index and high precordial leads 1
- Underestimating fever risk—fever is a critical trigger requiring immediate aggressive antipyretic treatment 3
- Relying solely on genetic testing—SCN5A mutations account for only 20-30% of cases; diagnosis is primarily clinical and electrocardiographic 3, 1